Form 4 for SERA SERA PROGNOSTICS, INC.
Accepted 2025-10-15 00:00:00 ET · period of report 2025-10-15 · accession 0001193125-25-240530 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-15 | 2025-10-15 | SERA | Inglis Tiffany Eul Davis | Chief Medical Off | A - Grant | $0.00 | +75.0K | 75.0K | New | $0 |
| D | 2025-10-15 | 2025-10-15 | SERA | Inglis Tiffany Eul Davis | Chief Medical Off | A - Grant | $0.00 | +107.0K | 107.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-10-15 | A | A | 75,000 | $0.00 | 75,000 | D | — | — | (F1) Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over four years as follows: 25% of the original grant amount vests on the first anniversary of the vesting commencement date, which is October 10, 2025, and 1/12 of the remaining amount vests in quarterly installments for three years thereafter, subject to the Reporting Person continuing to provide services to the issuer. |
| 2 | Derivative | Stock Option (right to buy) | 2025-10-15 | A | A | 107,000 | $0.00 | 107,000 | D | $3.13 · — to 2035-10-15 | 107,000 Class A Common Stock | (F2) These stock options vest over four years as follows: 25% of the original grant amount vests on the first anniversary of the vesting commencement date, which is October 10, 2025, and 1/36 of the remaining amount vests in monthly installments for three years thereafter, subject to the Reporting Person continuing to provide services to the issuer. |